131 related articles for article (PubMed ID: 1906865)
1. Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis.
Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1991 May; 27 Suppl C():9-14. PubMed ID: 1906865
[TBL] [Abstract][Full Text] [Related]
2. Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria.
Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1991 Jul; 28(1):25-34. PubMed ID: 1769941
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Hanberger H
Scand J Infect Dis Suppl; 1992; 81():1-52. PubMed ID: 1322561
[TBL] [Abstract][Full Text] [Related]
4. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
[TBL] [Abstract][Full Text] [Related]
5. Enterococci and aminoglycosides: evaluation of susceptibility and synergism of their combination with piperacillin.
Stefani S; Russo G; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):12-6. PubMed ID: 3103929
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
Gerçeker AA; Gürler B
J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
[TBL] [Abstract][Full Text] [Related]
8. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
9. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
Paglia P; Molinari G; Pesce A; Debbia EA
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
Werth BJ; Shireman LM
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
Sood P; Mandal A; Mishra B
Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
[TBL] [Abstract][Full Text] [Related]
13. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
Oie S; Sawa A; Kamiya A; Mizuno H
J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
[TBL] [Abstract][Full Text] [Related]
14. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against gram-positive and gram-negative bacteria.
Scaglione F; Dugnani S; Demartini G; Arcidiacono MM; Cocuzza CE; Fraschini F
Chemotherapy; 1995; 41(4):239-46. PubMed ID: 7555203
[TBL] [Abstract][Full Text] [Related]
16. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
[TBL] [Abstract][Full Text] [Related]
18. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
[TBL] [Abstract][Full Text] [Related]
19. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
Hanberger H; Nilsson LE; Svensson E; Maller R
J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.
Farina C; Russello G; Chinello P; Pasticci MB; Raglio A; Ravasio V; Rizzi M; Scarparo C; Vailati F; Suter F;
Chemotherapy; 2011; 57(5):426-33. PubMed ID: 22122863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
